IL10 and arthritic joint disease: The results showed that GMSC‐Exo have the same or even more immunoregulatory effects compared with GMSC in some aspects, such as promoting the secretion of IL‐10, inhibiting that of IL‐17A, and reducing the incidence of arthritis and bone erosion.